$RFMT $RIREG 31
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -5.3684   -3.7588    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
   -4.6065   -2.4127    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -5.3684   -5.2707    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.6747   -3.0009    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -4.0775   -4.4655    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -3.0591   -2.3969    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -5.3921   -1.0783    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -6.6747   -6.0326    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -4.0775   -5.9181    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -7.9852   -3.7588    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.3012   -4.4655    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -2.2972   -1.0468    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.6302    0.2675    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -7.9852   -5.2707    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.0828    0.2833    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -8.9821   -5.7248    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -2.3209    1.6295    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$MOL

  -ISIS-  03100810212D

 21 22  0  0  0  0  0  0  0  0999 V2000
    6.3582   -5.1569    0.0000 C   0  0  1  0  0  0  0  0  0  1  0  0
    7.1119   -3.8241    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    6.3582   -6.6581    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    5.0675   -4.4084    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    7.6382   -5.8570    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    8.6446   -3.8031    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    6.3318   -2.4967    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    5.0675   -7.4160    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    7.6382   -7.3002    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    3.7622   -5.1569    0.0000 C   0  0  1  0  0  0  0  0  0 10  0  0
    9.4025   -5.8570    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    9.4025   -2.4651    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    7.0856   -1.1588    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.7622   -6.6581    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.4295   -4.3873    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6235   -1.1430    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    2.7716   -7.1055    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    9.3815    0.1898    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
    8.3709    1.3530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8592    1.0793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8867    2.9191    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 10 15  1  1  0  0  4
 12 16  1  0  0  0  2
 14 17  2  0  0  0  2
 16 18  1  0  0  0  2
 18 19  1  0  0  0  4
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 10 14  1  0  0  0  2
 13 16  2  0  0  0  2
M  END
$DTYPE RXN:RXNREGNO
$DATUM 31
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-B
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 2 Step
$DTYPE RXN:VARIATION(1):RXNREF(2):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(2):PATH
$DATUM MTB5-R
$DTYPE RXN:VARIATION(1):RXNREF(2):STEP
$DATUM 2 Step
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00039457
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 31831
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 31831
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.2790   -2.8527    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0369   -1.5158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2790   -4.3581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0158   -2.1001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5632   -3.5528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5738   -1.4948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2526   -0.1842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0158   -5.1160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5632   -5.0002    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3211   -2.8527    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.3317   -3.5528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3317   -0.1526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0106    1.1579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3211   -4.3581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6580   -2.0790    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5527    1.1737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3159   -4.8055    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3107    2.5106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3001    3.6738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7842    3.4001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8159    5.2476    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 10 15  1  1  0  0  0
 12 16  1  0  0  0  0
 14 17  2  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 10 14  1  0  0  0  0
 13 16  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00028560
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.903170000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
$RFMT $RIREG 32
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -6.0483   -3.7588    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
   -5.2815   -2.4168    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.0483   -5.2666    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -7.3497   -3.0009    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -4.7566   -4.4613    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -3.7383   -2.4010    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -6.0746   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -7.3497   -6.0243    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -4.7566   -5.9098    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -8.6560   -3.7588    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.9846   -4.4613    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -2.9806   -1.0552    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -5.3052    0.2592    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -8.6560   -5.2666    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.7620    0.2750    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -9.6487   -5.7165    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -3.0043    1.6170    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$MOL

  -ISIS-  03100810212D

 19 20  0  0  0  0  0  0  0  0999 V2000
    5.3412   -4.4568    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
    6.0985   -3.1212    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    5.3412   -5.9622    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    4.0469   -3.7041    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    6.6218   -5.1590    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    7.6361   -3.1028    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    5.3183   -1.7947    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    4.0469   -6.7195    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    6.6218   -6.6047    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    2.7389   -4.4568    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    8.3888   -5.1590    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    8.3934   -1.7626    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    6.0756   -0.4500    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    2.7389   -5.9622    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    7.6131   -0.4362    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.7475   -6.4120    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    8.3704    0.9040    0.0000 N   0  3  0  0  0  0  0  0  0 17  0  0
    7.5581    2.2391    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8850    0.8994    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 17 18  2  0  0  0  4
 17 19  1  0  0  0  4
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  CHG  2  17   1  19  -1
M  END
$DTYPE RXN:RXNREGNO
$DATUM 32
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-C
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 1 Step
$DTYPE RXN:VARIATION(1):LITREF(1):LITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):AUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):LITREF(1):TITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_VOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_NO.
$DATUM 4
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_PG.
$DATUM 511
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_YEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_CODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_JRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):LITREF(1):FULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(1):ANALYTICAL
$DATUM RP-HPLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(2):ANALYTICAL
$DATUM TLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):QUAL_YIELD
$DATUM Minor
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):TIME
$DATUM 0-24
$DTYPE RXN:VARIATION(1):LITREF(2):LITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):AUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):LITREF(2):TITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_VOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_NO.
$DATUM 4
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_PG.
$DATUM 405
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_YEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_CODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_JRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):LITREF(2):FULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):LITREF(2):ANALYTICAL(1):ANALYTICAL
$DATUM (1)H NMR
$DTYPE RXN:VARIATION(1):LITREF(2):ANALYTICAL(2):ANALYTICAL
$DATUM Column Chromatography
$DTYPE RXN:VARIATION(1):LITREF(2):ANALYTICAL(3):ANALYTICAL
$DATUM MS
$DTYPE RXN:VARIATION(1):LITREF(2):ANALYTICAL(4):ANALYTICAL
$DATUM TLC-Autoradiography
$DTYPE RXN:VARIATION(1):LITREF(2):ANALYTICAL(5):ANALYTICAL
$DATUM TLC-UV
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):SPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):YIELD(1):QUAL_YIELD
$DATUM Minor
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):YIELD(1):QUANT_YIELD
$DATUM 2% of urinary radioactivity
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):YIELD(1):TIME
$DATUM 0-24
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):ANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):SPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):YIELD(1):QUAL_YIELD
$DATUM Minor
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):ANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):SPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):EXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):YIELD(1):QUANT_YIELD
$DATUM 8% of biliary radioactivity
$DTYPE RXN:VARIATION(1):LITREF(2):REAC_GRADE
$DATUM HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):RXNCLASS(1):RXNCLASS
$DATUM N-Oxidation
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00039451
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 31835
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 31835
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -0.6380   -2.1526    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.1193   -0.8170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6380   -3.6580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9323   -1.3999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6426   -2.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6569   -0.7986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6609    0.5095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9323   -4.4153    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6426   -4.3005    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2403   -2.1526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4096   -2.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4142    0.5416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0964    1.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2403   -3.6580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6339    1.8680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2317   -4.1078    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3912    3.2082    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    1.5789    4.5484    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9058    3.2036    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 17 18  2  0  0  0  0
 17 19  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  CHG  2  17   1  19  -1
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00028564
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.622640000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
$RFMT $RIREG 33
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -7.0524   -3.7588    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
   -6.2893   -2.4127    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -7.0524   -5.2707    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -8.3539   -3.0009    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.7566   -4.4655    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -4.7383   -2.3969    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -7.0787   -1.0783    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -8.3539   -6.0326    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -5.7566   -5.9181    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -9.6643   -3.7588    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -3.9804   -4.4655    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -3.9764   -1.0468    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -6.3156    0.2675    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -9.6643   -5.2707    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -4.7620    0.2833    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
  -10.6612   -5.7248    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -4.0001    1.6295    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$MOL

  -ISIS-  03100810212D

 20 21  0  0  1  0  0  0  0  0999 V2000
    4.3462   -4.1806    0.0000 C   0  0  1  0  0  0  0  0  0  1  0  0
    5.1035   -2.8410    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    4.3462   -5.6822    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    3.0504   -3.4276    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    5.6289   -4.8810    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    6.6445   -2.8279    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.3243   -1.5145    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.0504   -6.4395    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    5.6289   -6.3257    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    1.7458   -4.1806    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    7.3975   -4.8810    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    7.4019   -1.4839    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    5.0816   -0.1749    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    1.7458   -5.6822    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    6.6182   -0.1574    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.7564   -6.1331    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    7.3800    1.1822    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
    8.8947    0.9108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9060    2.0747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4857   -0.6346    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  6  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 17 18  1  0  0  0  4
 18 19  1  0  0  0  0
 18 20  2  0  0  0  0
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$DTYPE RXN:RXNREGNO
$DATUM 33
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-D
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 1 Step
$DTYPE RXN:VARIATION(1):LITREF(1):LITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):AUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):LITREF(1):TITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_VOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_PG.
$DATUM 74
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_YEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_CODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_JRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):LITREF(1):FULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(1):ANALYTICAL
$DATUM HPLC-UV
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(1):REAC_GRADE
$DATUM Racemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):RXNCLASS(1):RXNCLASS
$DATUM N-Acetylation
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00011675
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 18343
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 18343
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -1.3746   -1.9306    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6173   -0.5910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3746   -3.4322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6704   -1.1776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0919   -2.6310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9237   -0.5779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3965    0.7355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6704   -4.1895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0919   -4.0757    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9750   -1.9306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6767   -2.6310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6811    0.7661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6392    2.0751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9750   -3.4322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8974    2.0926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9644   -3.8831    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6592    3.4322    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1739    3.1608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1852    4.3253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7649    1.6154    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  6  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  2  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00010405
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.743180000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
$RFMT $RIREG 34
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -5.2059   -3.7505    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
   -4.4482   -2.4127    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -5.2059   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.5080   -2.9968    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -3.9233   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.9091   -2.3969    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -5.2296   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -6.5080   -6.0118    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -3.9233   -5.8973    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -7.8102   -3.7505    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.1554   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -2.1514   -1.0552    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.4719    0.2550    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -7.8102   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.9328    0.2708    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -8.8029   -5.7040    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -2.1751    1.6086    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$MOL

  -ISIS-  03100810212D

 18 19  0  0  0  0  0  0  0  0999 V2000
    6.1691   -3.7505    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
    6.9268   -2.4127    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    6.1691   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    4.8747   -2.9968    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    7.4517   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    6.1454   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    8.4659   -2.3969    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.8747   -6.0118    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    7.4517   -5.8973    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    3.5685   -3.7505    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    9.2196   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    6.9031    0.2550    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    9.2236   -1.0552    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.5685   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    8.4422    0.2708    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    6.1218    1.5810    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5779   -5.7040    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    9.1999    1.6086    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  2  0  0  0  2
  2  7  1  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  1  0  0  0  2
  7 13  2  0  0  0  2
  8 14  1  0  0  0  2
 12 15  2  0  0  0  2
 12 16  1  0  0  0  4
 14 17  2  0  0  0  2
 15 18  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  1  0  0  0  2
M  END
$DTYPE RXN:RXNREGNO
$DATUM 34
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-E
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 1 of 2
$DTYPE RXN:VARIATION(1):LITREF(1):LITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):AUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):LITREF(1):TITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_VOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_NO.
$DATUM 4
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_PG.
$DATUM 405
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_YEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_CODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_JRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):LITREF(1):FULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):LITREF(1):REAC_GRADE
$DATUM HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):LITREF(1):PROD_GRADE
$DATUM Conjugate Isolated
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):RXNCLASS(1):RXNCLASS
$DATUM Aromatic Hydroxylation
$DTYPE RXN:VARIATION(1):RXNCLASS(2):RXNCLASS
$DATUM C-Hydroxylation
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00046670
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 33781
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 33781
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1657    3.8477    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
 12 15  2  0  0  0  0
 12 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 18  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  1  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00031101
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.482800000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
$RFMT $RIREG 35
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -5.2017   -3.7588    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
   -4.4399   -2.4168    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -5.2017   -5.2666    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.5080   -3.0009    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -3.9150   -4.4613    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.2254   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.8966   -2.4010    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -6.5080   -6.0243    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -3.9150   -5.9098    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -7.8143   -3.7588    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.1429   -4.4613    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -4.4636    0.2592    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -2.1389   -1.0552    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -7.8143   -5.2666    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.9203    0.2750    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -5.2490    1.5894    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8071   -5.7165    0.0000 O   0  0  0  0  0  0  0  0  0 17  0  0
   -2.1626    1.6170    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  2  0  0  0  2
  2  7  1  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  1  0  0  0  2
  7 13  2  0  0  0  2
  8 14  1  0  0  0  2
 12 15  2  0  0  0  2
 12 16  1  0  0  0  4
 14 17  2  0  0  0  2
 15 18  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  1  0  0  0  2
M  END
$MOL

  -ISIS-  03100810212D

 22 23  0  0  0  0  0  0  0  0999 V2000
    6.1779   -4.3806    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
    6.9335   -3.0418    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    6.1779   -5.8780    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    4.8930   -3.6252    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    7.4582   -5.0819    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    6.1598   -1.7207    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    8.4672   -3.0282    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    4.8930   -6.6337    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    7.4582   -6.5206    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    3.5855   -4.3806    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    9.2226   -5.0819    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    6.9064   -0.3815    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    9.2271   -1.6891    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.5855   -5.8780    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    8.4446   -0.3680    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    6.1327    0.9395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5950   -6.3262    0.0000 O   0  0  0  0  0  0  0  0  0 17  0  0
    9.2045    0.9712    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
    4.6217    0.6455    0.0000 S   0  0  3  0  0  0  0  0  0  0  0  0
    3.1287    0.3515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3277    2.1556    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9202   -0.8700    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  2  0  0  0  2
  2  7  1  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  1  0  0  0  2
  7 13  2  0  0  0  2
  8 14  1  0  0  0  2
 12 15  2  0  0  0  2
 12 16  1  0  0  0  4
 14 17  2  0  0  0  2
 15 18  1  0  0  0  2
 16 19  1  0  0  0  4
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 19 22  2  0  0  0  0
 10 14  1  0  0  0  2
 13 15  1  0  0  0  2
M  END
$DTYPE RXN:RXNREGNO
$DATUM 35
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-E
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 2 of 2
$DTYPE RXN:VARIATION(1):LITREF(1):LITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):AUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):LITREF(1):TITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_VOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_NO.
$DATUM 4
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_PG.
$DATUM 405
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_YEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_CODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_JRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):LITREF(1):FULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(1):ANALYTICAL
$DATUM (1)H NMR
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(2):ANALYTICAL
$DATUM Column Chromatography
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(3):ANALYTICAL
$DATUM HPLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(4):ANALYTICAL
$DATUM IR
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(5):ANALYTICAL
$DATUM MS
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(6):ANALYTICAL
$DATUM RP-HPLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):SPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):QUAL_YIELD
$DATUM Minor
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):QUANT_YIELD
$DATUM 8% of urinary radioactivity
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):TIME
$DATUM 0-24
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):CONJUGATES
$DATUM O-Sulfate
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):ANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):SPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):YIELD(1):QUAL_YIELD
$DATUM Minor
$DTYPE RXN:VARIATION(1):LITREF(1):REAC_GRADE
$DATUM Presumed Structure; Not Isolated
$DTYPE RXN:VARIATION(1):LITREF(1):COMMENTS
$DATUM Conjugate hydrolyzed with sulfatase
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):RXNCLASS(1):RXNCLASS
$DATUM O-Sulfation
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00046671
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 33781
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 33781
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1657    3.8477    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
 12 15  2  0  0  0  0
 12 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 18  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  1  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00031101
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.482800000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 33787
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 33787
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -0.1221   -2.0806    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6377   -0.7418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1221   -3.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4112   -1.3252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1624   -2.7861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1402    0.5835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1755   -0.7282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4112   -4.3420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1624   -4.2289    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7228   -2.0806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9309   -2.7861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6106    1.9268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9354    0.6151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7228   -3.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1529    1.9403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1673    3.2520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7133   -4.0345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9128    3.2837    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6825    2.9580    0.0000 S   0  0  3  0  0  0  0  0  0  0  0  0
   -3.1796    2.6640    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9765    4.4777    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3840    1.4383    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
 12 15  2  0  0  0  0
 12 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 19 22  2  0  0  0  0
 10 14  1  0  0  0  0
 13 15  1  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00031107
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 3.283430000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
$RFMT $RIREG 36
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -5.2017   -3.7588    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
   -4.4399   -2.4168    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -5.2017   -5.2666    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.5080   -3.0009    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -3.9150   -4.4613    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.8966   -2.4010    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -5.2254   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -6.5080   -6.0243    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -3.9150   -5.9098    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -7.8143   -3.7588    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.1429   -4.4613    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -2.1389   -1.0552    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.4636    0.2592    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -7.8143   -5.2666    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.9203    0.2750    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -8.8071   -5.7165    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -2.1626    1.6170    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$MOL

  -ISIS-  03100810212D

 22 23  0  0  0  0  0  0  0  0999 V2000
    6.1779   -4.3806    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
    6.9335   -3.0418    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    6.1779   -5.8780    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    4.8930   -3.6252    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    7.4582   -5.0819    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    6.1598   -1.7207    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    8.4672   -3.0282    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.8930   -6.6337    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    7.4582   -6.5206    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    3.5855   -4.3806    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    9.2226   -5.0819    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    6.9064   -0.3815    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    9.2271   -1.6891    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.5855   -5.8780    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    8.4446   -0.3680    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    6.1327    0.9395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5950   -6.3262    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    9.2045    0.9712    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
    4.6217    0.6455    0.0000 S   0  0  3  0  0  0  0  0  0  0  0  0
    3.1287    0.3515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3277    2.1556    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9202   -0.8700    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  2  0  0  0  2
  2  7  1  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  1  0  0  0  2
  7 13  2  0  0  0  2
  8 14  1  0  0  0  2
 12 15  2  0  0  0  2
 12 16  1  0  0  0  4
 14 17  2  0  0  0  2
 15 18  1  0  0  0  2
 16 19  1  0  0  0  4
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 19 22  2  0  0  0  0
 10 14  1  0  0  0  2
 13 15  1  0  0  0  2
M  END
$DTYPE RXN:RXNREGNO
$DATUM 36
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-E
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 2 Step
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00046672
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 33787
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 33787
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -0.1221   -2.0806    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6377   -0.7418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1221   -3.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4112   -1.3252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1624   -2.7861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1402    0.5835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1755   -0.7282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4112   -4.3420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1624   -4.2289    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7228   -2.0806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9309   -2.7861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6106    1.9268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9354    0.6151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7228   -3.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1529    1.9403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1673    3.2520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7133   -4.0345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9128    3.2837    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6825    2.9580    0.0000 S   0  0  3  0  0  0  0  0  0  0  0  0
   -3.1796    2.6640    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9765    4.4777    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3840    1.4383    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
 12 15  2  0  0  0  0
 12 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 19 22  2  0  0  0  0
 10 14  1  0  0  0  0
 13 15  1  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00031107
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 3.283430000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
$RFMT $RIREG 37
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -6.9774   -3.7588    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
   -6.2143   -2.4168    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.9774   -5.2666    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -8.2789   -3.0009    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.6858   -4.4613    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -4.6674   -2.4010    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -7.0037   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -8.2789   -6.0243    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -5.6858   -5.9098    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -9.5852   -3.7588    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -3.9137   -4.4613    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -3.9097   -1.0552    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -6.2406    0.2592    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -9.5852   -5.2666    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -4.6911    0.2750    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
  -10.5779   -5.7165    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -3.9334    1.6170    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  4
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$MOL

  -ISIS-  03100810212D

 18 18  0  0  0  0  0  0  0  0999 V2000
    5.8507   -2.3626    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
    7.1988   -1.5685    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    4.6325   -1.5877    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    5.0608   -3.8503    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    6.5870   -3.7781    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    8.4990   -2.3241    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    7.1988   -0.0711    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.3275   -2.3626    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    3.5922   -3.8455    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    5.7544   -5.1504    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    8.1036   -4.2401    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    9.7990   -1.5685    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    8.4990    0.6852    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    2.0901   -1.5925    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    9.7990   -0.0663    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.8195   -2.3289    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0901   -0.1674    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   11.1032    0.6852    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  4  9  1  0  0  0  2
  4 10  2  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  1  0  0  0  4
 14 17  2  0  0  0  2
 15 18  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$DTYPE RXN:RXNREGNO
$DATUM 37
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-F
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 1 Step
$DTYPE RXN:VARIATION(1):LITREF(1):LITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):AUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):LITREF(1):TITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_VOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_NO.
$DATUM 4
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_PG.
$DATUM 405
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_YEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_CODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_JRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):LITREF(1):FULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(1):ANALYTICAL
$DATUM (1)H NMR
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(2):ANALYTICAL
$DATUM Chemical Assay
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(3):ANALYTICAL
$DATUM Column Chromatography
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(4):ANALYTICAL
$DATUM MS
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(5):ANALYTICAL
$DATUM RP-HPLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(6):ANALYTICAL
$DATUM Radiochemical Detection
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(7):ANALYTICAL
$DATUM TLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):SPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):QUAL_YIELD
$DATUM Minor
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):QUANT_YIELD
$DATUM 3% of urinary radioactivity
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):TIME
$DATUM 0-24
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):ANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):SPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):YIELD(1):QUAL_YIELD
$DATUM Minor
$DTYPE RXN:VARIATION(1):LITREF(1):REAC_GRADE
$DATUM HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):LITREF(1):PROD_GRADE
$DATUM Presumed Structure; Site of Piperidine Splitting Uncertain
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):RXNCLASS(1):RXNCLASS
$DATUM Hydrolysis
$DTYPE RXN:VARIATION(1):RXNCLASS(2):RXNCLASS
$DATUM Ring Opening
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00046673
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 33782
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 33782
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 18 18  0  0  0  0  0  0  0  0999 V2000
   -0.2743   -0.0626    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.0780    0.7315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4967    0.7123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0684   -1.5545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4620   -1.4823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3823   -0.0241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0780    2.2331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8058   -0.0626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5411   -1.5497    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3706   -2.8587    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9828   -1.9443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6865    0.7315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3823    2.9935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0474    0.7075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6865    2.2379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3180   -0.0289    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0474    2.1368    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9907    2.9935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 18  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00031102
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.502960000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
$RFMT $RIREG 38
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -5.8476   -3.7505    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
   -5.0899   -2.4127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8476   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1497   -2.9968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5650   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5508   -2.3969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8713   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1497   -6.0118    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5650   -5.8973    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4518   -3.7505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7971   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7931   -1.0552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1136    0.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4518   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5745    0.2708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4446   -5.7040    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8168    1.6086    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$MOL

  -ISIS-  03100810212D

 17 18  0  0  1  0  0  0  0  0999 V2000
    5.5274   -3.7505    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.2851   -2.4127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5274   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2330   -2.9968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8100   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8242   -2.3969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5037   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2330   -6.0118    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8100   -5.8973    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9268   -3.7505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5779   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5819   -1.0552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2614    0.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9268   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8005    0.2708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9362   -5.7040    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5582    1.6086    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:RXNREGNO
$DATUM 38
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-G
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 1 of 2
$DTYPE RXN:VARIATION(1):LITREF(1):LITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):AUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):LITREF(1):TITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_VOL.
$DATUM 39
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_NO.
$DATUM 11
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_PG.
$DATUM 1136
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_YEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_CODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_JRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):LITREF(1):FULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 39 (11), 1136.
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(1):ANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(2):ANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):EXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):ANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):YIELD(1):QUANT_YIELD
$DATUM 26.29
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):YIELD(1):TIME
$DATUM 0-48
$DTYPE RXN:VARIATION(1):LITREF(1):REAC_GRADE
$DATUM Racemate
$DTYPE RXN:VARIATION(1):LITREF(2):LITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):AUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):LITREF(2):TITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_VOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_NO.
$DATUM 5
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_PG.
$DATUM 538
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_YEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_CODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_JRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):LITREF(2):FULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 17 (5), 538.
$DTYPE RXN:VARIATION(1):LITREF(2):ANALYTICAL(1):ANALYTICAL
$DATUM HPLC-UV
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):EXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):YIELD(1):TIME
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):ANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):EXCRETION
$DATUM Saliva
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):YIELD(1):TIME
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):ANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):YIELD(1):TIME
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):RXNCLASS(1):RXNCLASS
$DATUM Optical Resolution
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00025025
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 25652
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 25652
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  1  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00020517
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
$RFMT $RIREG 39
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 17 18  0  0  1  0  0  0  0  0999 V2000
   -7.6899   -3.7588    0.0000 C   0  0  1  0  0  0  0  0  0  1  2  0
   -6.9268   -2.4127    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -7.6899   -5.2707    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -8.9914   -3.0009    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -6.3975   -4.4655    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.3758   -2.3969    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -7.7162   -1.0783    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -8.9914   -6.0326    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -6.3975   -5.9181    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
  -10.3018   -3.7588    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -4.6179   -4.4655    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -4.6139   -1.0468    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -6.9531    0.2675    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
  -10.3018   -5.2707    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -5.3995    0.2833    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
  -11.2987   -5.7248    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -4.6376    1.6295    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  1  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$MOL

  -ISIS-  03100810212D

 20 21  0  0  1  0  0  0  0  0999 V2000
    4.9879   -4.1806    0.0000 C   0  0  1  0  0  0  0  0  0  1  2  0
    5.7452   -2.8410    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    4.9879   -5.6822    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    3.6921   -3.4276    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    6.2706   -4.8810    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    7.2862   -2.8279    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.9660   -1.5145    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.6921   -6.4395    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    6.2706   -6.3257    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    2.3875   -4.1806    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    8.0392   -4.8810    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    8.0436   -1.4839    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    5.7233   -0.1749    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    2.3875   -5.6822    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    7.2599   -0.1574    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.3981   -6.1331    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    8.0217    1.1822    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
    9.5364    0.9108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5477    2.0747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1274   -0.6346    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  6  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 17 18  1  0  0  0  4
 18 19  1  0  0  0  0
 18 20  2  0  0  0  0
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$DTYPE RXN:RXNREGNO
$DATUM 39
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-G
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 2 of 2
$DTYPE RXN:VARIATION(1):LITREF(1):LITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):AUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):LITREF(1):TITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_VOL.
$DATUM 39
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_NO.
$DATUM 11
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_PG.
$DATUM 1136
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_YEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_CODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_JRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):LITREF(1):FULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 39 (11), 1136.
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(1):ANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(2):ANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):EXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):ANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):YIELD(1):QUAL_YIELD
$DATUM Minor
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):YIELD(1):QUANT_YIELD
$DATUM 2.2
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(2):YIELD(1):TIME
$DATUM 0-48
$DTYPE RXN:VARIATION(1):LITREF(2):LITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):AUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):LITREF(2):TITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_VOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_NO.
$DATUM 5
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_PG.
$DATUM 538
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_YEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_CODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):LITREF(2):JOURNAL_JRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):LITREF(2):FULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 17 (5), 538.
$DTYPE RXN:VARIATION(1):LITREF(2):ANALYTICAL(1):ANALYTICAL
$DATUM HPLC-UV
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):EXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(1):YIELD(1):TIME
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):ANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):EXCRETION
$DATUM Saliva
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(2):YIELD(1):TIME
$DATUM 2
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):ANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):ROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(2):ANIMAL(3):YIELD(1):TIME
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):RXNCLASS(1):RXNCLASS
$DATUM N-Acetylation
$DTYPE RXN:VARIATION(1):RXNCLASS(2):RXNCLASS
$DATUM N-Acylation
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00025026
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 25652
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 25652
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  1  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00020517
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 18343
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 18343
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -1.3746   -1.9306    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6173   -0.5910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3746   -3.4322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6704   -1.1776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0919   -2.6310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9237   -0.5779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3965    0.7355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6704   -4.1895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0919   -4.0757    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9750   -1.9306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6767   -2.6310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6811    0.7661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6392    2.0751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9750   -3.4322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8974    2.0926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9644   -3.8831    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6592    3.4322    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1739    3.1608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1852    4.3253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7649    1.6154    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  6  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  2  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00010405
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.743180000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
$RFMT $RIREG 40
$RXN

      ISIS     031020081021

  1  1
$MOL

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -5.2059   -3.7505    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
   -4.4482   -2.4127    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -5.2059   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.5080   -2.9968    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -3.9233   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.9091   -2.3969    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -5.2296   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -6.5080   -6.0118    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -3.9233   -5.8973    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -7.8102   -3.7505    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.1554   -4.4530    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -2.1514   -1.0552    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.4719    0.2550    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -7.8102   -5.2541    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.9328    0.2708    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -8.8029   -5.7040    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -2.1751    1.6086    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$MOL

  -ISIS-  03100810212D

 18 19  0  0  0  0  0  0  0  0999 V2000
    6.1663   -4.3285    0.0000 C   0  0  3  0  0  0  0  0  0  1  0  0
    6.9225   -2.9915    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    6.1663   -5.8321    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    4.8698   -3.5767    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    7.4447   -5.0308    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    8.4621   -2.9780    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    6.1392   -1.6680    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    4.8698   -6.5884    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    7.4447   -6.4758    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    3.5643   -4.3285    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    9.2139   -5.0308    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    9.2184   -1.6365    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    6.9000   -0.3265    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.5643   -5.8321    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    8.4351   -0.3084    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    2.5739   -6.2822    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    9.1959    1.0286    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
    8.1830    2.1850    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  2
  1  3  1  0  0  0  2
  1  4  1  0  0  0  2
  1  5  1  0  0  0  2
  2  6  1  0  0  0  2
  2  7  2  0  0  0  2
  3  8  1  0  0  0  2
  3  9  2  0  0  0  2
  4 10  1  0  0  0  2
  5 11  1  0  0  0  2
  6 12  2  0  0  0  2
  7 13  1  0  0  0  2
  8 14  1  0  0  0  2
 12 15  1  0  0  0  2
 14 16  2  0  0  0  2
 15 17  1  0  0  0  2
 17 18  1  0  0  0  4
 10 14  1  0  0  0  2
 13 15  2  0  0  0  2
M  END
$DTYPE RXN:RXNREGNO
$DATUM 40
$DTYPE RXN:VARIATION(1):RXNTEXT(1):RXNTEXT
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):RXNTEXT(2):RXNTEXT
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):RXNTEXT(3):RXNTEXT
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):RXNTEXT(4):RXNTEXT
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):RXNREF(1):EXTREG
$DATUM MTB5
$DTYPE RXN:VARIATION(1):RXNREF(1):PATH
$DATUM MTB5-H
$DTYPE RXN:VARIATION(1):RXNREF(1):STEP
$DATUM 1 Step
$DTYPE RXN:VARIATION(1):LITREF(1):LITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):AUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):LITREF(1):TITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_VOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_NO.
$DATUM 4
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_PG.
$DATUM 511
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_YEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_CODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):LITREF(1):JOURNAL_JRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):LITREF(1):FULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(1):ANALYTICAL
$DATUM MS
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(2):ANALYTICAL
$DATUM RP-HPLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANALYTICAL(3):ANALYTICAL
$DATUM TLC
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):ANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):SPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):EXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):QUAL_YIELD
$DATUM Major
$DTYPE RXN:VARIATION(1):LITREF(1):ANIMAL(1):YIELD(1):TIME
$DATUM 0-24
$DTYPE RXN:VARIATION(1):SOLVENT(1):SOLVENT_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):REGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(1):MANALYTICAL
$DATUM Chiral HPLC
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANALYTICAL(2):MANALYTICAL
$DATUM Spectrophotometry
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MSPECIES
$DATUM Human
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):MEXCRETION
$DATUM Plasma
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(1):MANIMAL(1):PHARM_KINETIC
$DATUM Y
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(1):MANALYTICAL
$DATUM (14)C
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANALYTICAL(2):MANALYTICAL
$DATUM Liquid Scintillation Counter
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MANIMAL_NO
$DATUM 1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):TOTAL_ACT
$DATUM 60.0
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(1):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MANIMAL_NO
$DATUM 2
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MSPECIES
$DATUM Rat
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):TOTAL_ACT
$DATUM 25.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):MYIELD(1):MTIME
$DATUM 0-96
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(2):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MANIMAL_NO
$DATUM 3
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MEXCRETION
$DATUM Urine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):TOTAL_ACT
$DATUM 46.7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(3):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MANIMAL_NO
$DATUM 4
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MEXCRETION
$DATUM Feces
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):TOTAL_ACT
$DATUM 5.6
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(4):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MANIMAL_NO
$DATUM 5
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MSPECIES
$DATUM Rat (Bile Duct Cannulated)
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MROUTE
$DATUM Oral
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MEXCRETION
$DATUM Bile
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):TOTAL_ACT
$DATUM 55.1
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):MYIELD(1):MTIME
$DATUM 0-72
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(6):MANIMAL(5):PHARM_KINETIC
$DATUM N
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:VARIATION(1):SOLVENT(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:VARIATION(1):RXNCLASS(1):RXNCLASS
$DATUM N-Hydroxylation
$DTYPE RXN:VARIATION(1):MDLNUMBER
$DATUM RMTB00039460
$DTYPE RXN:REACTANT_LINK(1):REGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):REACTANT_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(1):SYMBOL
$DATUM Aminoglutethimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(2):SYMBOL
$DATUM 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(3):SYMBOL
$DATUM Cytadren
$DTYPE RXN:REACTANT_LINK(1):MOL(1):SYMBOL(4):SYMBOL
$DATUM 2-(4-Aminophenyl)-2-ethylglutarimide
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):CAS
$DATUM 125-84-8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CASINFO(1):DERIVATIVE
$DATUM None
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MLITREF_NO
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MTITLE
$DATUM Pharmacokinetics of S- and R-Enantiomers of Aminoglutethimide following O+
ral Administration of Racemic Drug in Breast Cancer Patients
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MVOL.
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MNO.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MPG.
$DATUM 1 36
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MYEAR
$DATUM 1999
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MCODEN
$DATUM JCPCBR
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MJOURNAL_MJRNL
$DATUM J Clin Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Ezzat, A.; El-Warith, A. A.; Nicholls, +
P. J.; J Clin Pharmacol [JCPCBR] 1999, 3 (1), 1 36.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(1):TOPICS
$DATUM Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MLITREF_NO
$DATUM 2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MAUTHOR
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MTITLE
$DATUM Liquid Chromatographic Separation and Measurement of Optical Isomers of A+
minoglutethimide and Its Acetyl Metabolite in Plasma, Saliva, and Urine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MVOL.
$DATUM 1
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MNO.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MPG.
$DATUM 538
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MYEAR
$DATUM 1995
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MCODEN
$DATUM TDMODV
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MJOURNAL_MJRNL
$DATUM Ther Drug Monit
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(2):MFULL_CITATION
$DATUM Alshowaier, I. A.; El-Yazigi, A.; Essat, A.; El-Warith, A. A.; Nicholls, +
P. J.; Ther Drug Monit [TDMODV] 1995, 1 (5), 538.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MLITREF_NO
$DATUM 3
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MAUTHOR
$DATUM Aboul-Enein, H. Y.; Islam, M. R.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MTITLE
$DATUM Direct Enantiomeric High Performance Liquid Chromatographic Separation of+
 Aminoglutethimide and its Major Metabolite on a Series of Chiralcel OD and Chir+
alcel OJ Columns and its Application to Biological Fluids
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MVOL.
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MPG.
$DATUM 74
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MYEAR
$DATUM 1991
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MCODEN
$DATUM BICHE2
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MJOURNAL_MJRNL
$DATUM Biomed Chromatogr
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(3):MFULL_CITATION
$DATUM Aboul-Enein, H. Y.; Islam, M. R.; Biomed Chromatogr [BICHE2] 1991, 5, 74.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MLITREF_NO
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MAUTHOR
$DATUM Dalrymple, P. D.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MVOL.
$DATUM 18
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MPG.
$DATUM 75
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MYEAR
$DATUM 1988
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MCODEN
$DATUM XENOBH
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MJOURNAL_MJRNL
$DATUM Xenobiotica
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(4):MFULL_CITATION
$DATUM Dalrymple, P. D.; Nicholls, P. J.; Xenobiotica [XENOBH] 1988, 18, 75.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MLITREF_NO
$DATUM 5
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MAUTHOR
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS. Identification of Four New Uri+
nary Metabolites
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MVOL.
$DATUM 12
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MPG.
$DATUM 511
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MYEAR
$DATUM 1984
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):MFULL_CITATION
$DATUM Foster, A. B.; Griggs, L. J.; Howe, I.; Jarman, M.; Leung, C.-S.; Manson,+
 D.; Rowlands, M. G.; Drug Metab Dispos [DMDSAI] 1984, 12 (4), 511.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(5):TOPICS
$DATUM Metabolic Pathways
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MLITREF_NO
$DATUM 6
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MAUTHOR
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MTITLE
$DATUM METABOLISM OF AMINOGLUTETHIMIDE IN THE RAT
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MVOL.
$DATUM 10
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MNO.
$DATUM 4
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MPG.
$DATUM 405
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MYEAR
$DATUM 1982
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MCODEN
$DATUM DMDSAI
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MJOURNAL_MJRNL
$DATUM Drug Metab Dispos
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):MFULL_CITATION
$DATUM Egger, H.; Bartlett, F.; Itterly, W.; Rodebaugh, R.; Shimanskas, C.; Drug+
 Metab Dispos [DMDSAI] 1982, 10 (4), 405.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(6):TOPICS
$DATUM (14)C-Labeled; HCl Salt; Racemate
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MLITREF_NO
$DATUM 7
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MVOL.
$DATUM 24
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MPG.
$DATUM 150S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MYEAR
$DATUM 1972
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(7):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1972, 24, 150+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MLITREF_NO
$DATUM 8
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MAUTHOR
$DATUM Douglas, J. S.; Nicholls, P. J.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MVOL.
$DATUM 17
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MPG.
$DATUM 115S
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MYEAR
$DATUM 1965
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MCODEN
$DATUM JPPMAB
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MJOURNAL_MJRNL
$DATUM J Pharm Pharmacol
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MLITREF(8):MFULL_CITATION
$DATUM Douglas, J. S.; Nicholls, P. J.; J Pharm Pharmacol [JPPMAB] 1965, 17, 115+
S.
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(1):ACTIVITY
$DATUM Anticonvulsant
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(2):ACTIVITY
$DATUM Antiedemic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(3):ACTIVITY
$DATUM Antihyperaldosterismic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(4):ACTIVITY
$DATUM Antineoplastic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(5):ACTIVITY
$DATUM Aromatase Inhibitor
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(6):ACTIVITY
$DATUM Cytostatic
$DTYPE RXN:REACTANT_LINK(1):MOL(1):ACTIVITY(7):ACTIVITY
$DATUM Sedative
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(1):USE
$DATUM Treatment of Adrenocortical Tumors
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(2):USE
$DATUM Treatment of Breast and Prostate Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(3):USE
$DATUM Treatment of Epilepsy
$DTYPE RXN:REACTANT_LINK(1):MOL(1):USE(4):USE
$DATUM Treatment of Metastatic Breast Cancer
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(1):CMPDCLASS
$DATUM Aromatic amine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):CMPDCLASS(2):CMPDCLASS
$DATUM Piperidine
$DTYPE RXN:REACTANT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.322810000000000e+002
$DTYPE RXN:PRODUCT_LINK(1):REGNO
$DATUM 31829
$DTYPE RXN:PRODUCT_LINK(1):PRODUCT_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLREGNO
$DATUM 31829
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.1170   -2.0618    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6392   -0.7248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1170   -3.5654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4135   -1.3100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1614   -2.7641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1788   -0.7113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1441    0.5987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4135   -4.3217    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1614   -4.2091    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9306   -2.7641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9351    0.6302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6167    1.9402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -3.5654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1518    1.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7094   -4.0155    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9126    3.2953    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8997    4.4567    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 17 18  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00028558
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS_NO
$DATUM 1
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):ANCESTORS
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLREGNO
$DATUM 5
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MOLSTRUCTURE
$DATUM $MFMT

  -ISIS-  03100810212D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1184   -1.4838    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6393   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -0.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1784   -0.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1421    1.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4128   -3.7451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1642   -3.6306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9321   -2.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9361    1.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6156    2.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7190   -2.9874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1547    2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7096   -3.4373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    3.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 17  1  0  0  0  0
 10 14  1  0  0  0  0
 13 15  2  0  0  0  0
M  END
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):ANCESTOR_LINK(1):MOL(1):MDLNUMBER
$DATUM MMTB00000005
$DTYPE RXN:PRODUCT_LINK(1):MOL(1):MOLECULAR.WEIGHT
$DATUM 2.482800000000000e+002
$DTYPE RXN:SCHEMEID
$DATUM MTB5
